J9326 Telisotuzumab vedotin-tllv
J-Codes
Also known as: telisotuzumab vedotin, Subtam
Injection of telisotuzumab vedotin-tllv, an antibody-drug conjugate targeting c-Met receptor. Used for solid tumors with c-Met expression.
Clinical Context
Used for metastatic non-small cell lung cancer with c-Met expression. Antibody-drug conjugate targeting hepatocyte growth factor receptor.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.